%20&%20Hidden%20Heart%20Risk.png)
The Health Pulse
🎙️ The Health Pulse – Your quick guide to better health!
In under 20 minutes, get expert insights on health and nutrition. Stay informed, and take charge of your wellness with actionable tips. Whether optimizing your health or exploring diagnostics, we keep it simple and insightful.
Listen, learn, and take control—one pulse at a time! 🔬✨
The Health Pulse
Episode 136 | FIB-4 and Metabolic Liver Disease
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Your AST and ALT can be completely normal while liver fibrosis is quietly developing. In this episode of The Health Pulse, we explore one of the biggest blind spots in routine liver testing and explain why FIB-4 can provide important information that a standard liver panel may miss.
We begin with metabolic dysfunction-associated steatotic liver disease (MASLD), the condition formerly known as NAFLD. Closely connected to insulin resistance, visceral fat, prediabetes, and type 2 diabetes, MASLD can progress silently from excess liver fat to inflammation and eventually fibrosis—the accumulation of scar tissue that ultimately determines much of the long-term risk of cirrhosis and liver-related complications.
We break down the metabolic biology behind that progression, including de novo lipogenesis, where excess energy—particularly from carbohydrates and fructose—can be converted into fat inside the liver. As metabolic dysfunction progresses, lipotoxicity, oxidative stress, and inflammation can push simple steatosis toward MASH and eventually fibrosis.
Then we address the problem with relying on liver enzymes alone. AST and ALT primarily reflect cellular injury; they do not directly measure fibrosis. Someone can therefore have clinically important liver disease without dramatically elevated enzymes, making a row of green check marks on a laboratory portal potentially misleading.
That's where the FIB-4 index becomes useful. Using only age, AST, ALT, and platelet count, FIB-4 provides a noninvasive first-line estimate of the likelihood of advanced liver fibrosis. We explain the commonly used low-, intermediate-, and high-risk thresholds, why age changes interpretation, and how platelet counts and the relationship between AST and ALT can provide clues about advancing disease.
An abnormal FIB-4 isn't a diagnosis. Instead, it can identify people who may benefit from further evaluation with tools such as transient elastography (FibroScan) or the Enhanced Liver Fibrosis (ELF) test.
Finally, we discuss what can change the trajectory. Weight reduction when appropriate, resistance and aerobic exercise, improved insulin sensitivity, and nutritional strategies can substantially reduce liver fat and metabolic stress. We also look at the evolving treatment landscape, including medications such as resmetirom and semaglutide for appropriately selected patients with MASH and fibrosis.
And because MASLD rarely exists in isolation, we connect liver health back to cardiovascular risk through ApoB and the broader metabolic picture.
If your annual physical says your liver enzymes are "normal," this episode explains why that shouldn't always be the end of the conversation—and how information already sitting inside routine bloodwork may help identify fibrosis risk earlier.
📞 Need lab work done from the comfort of home? QLM offers fast, reliable mobile phlebotomy services—no clinic visit required.
📅 Book your appointment or learn more at:
👉 Quick Lab Mobile
📧 Contact us: info@quicklabmobile.com
💬 Enjoyed the episode? Leave us a review and let us know what topics you'd like us to cover next! Your feedback helps us bring you the content that matters most.
Disclaimer: The information provided in this podcast is for informational purposes only and should not be considered medical advice. The content discussed is based on research, expert insights, and reputable sources, but it does not replace professional medical consultation, diagnosis, or treatment. We strive to present accurate and up-to-date information, medical research is constantly evolving. Listeners should always verify details with trusted health organizations, before making any health-related decisions. If you are experiencing a medical emergency, such as severe pain, difficulty breathing, or other urgent symptoms, call your local emergency services immediately. By listening to this podcast, you acknowledge that The Health Pulse and its creators are not responsible for any actions taken based on the content of this episode. Your health and well-being should always be guided by the advice of qualified medical professionals.
Welcome To Health Pulse
NicoletteWelcome to the Health Pulse, your go-to source for quick, actionable insights on health, wellness, and diagnostics. Whether you're looking to optimize your well-being or stay informed about the latest in-medical testing, we've got you covered. Join us as we break down key health topics in just minutes. Let's dive in.
The Normal Lab Illusion
MarkMillions of people will log into their patient portals today. Um, they'll scroll down to their liver panel and they'll see a column of these comforting green check marks.
RachelRight.
MarkAnd they just assume they're in perfect health. And they are completely wrong.
RachelYeah, they are.
MarkWelcome to the deep dive. Yeah. Today is August 25th, 2026, and our mission today is to shatter that incredibly dangerous illusion.
RachelIt really is dangerous.
MarkYeah. We are looking at this brilliant, honestly, somewhat terrifying article from Quick Lab Mobile. And it exposes this silent epidemic that is quietly dismantling our body's central processing plant, which is the liver.
RachelYeah. And the scale of this is it's really hard to overstate. It is happening in plain sight, you know, entirely masked by these standard medical reference ranges.
MarkRight.
RachelWhich give patients and frankly, I mean a lot of doctors, just a false sense of security.
MarkWow. So we're going to explore how a really simple, practically hidden math formula can decode the routine, supposedly, you know, normal blood work you already get, and how it can literally save lives. Okay. Let's unpack this. Because the most mind-blowing part to me is that almost everyone listening right now likely already has the exact data required for this life-saving formula.
RachelThey do, yeah.
MarkSitting in a PDF from their last annual physical.
RachelBut before we get to the mathematical solution, we really have to look at the underlying biology.
MASLD And The Metabolic Cause
RachelTrevor Burrus, Jr.
MarkThe rebranding part.
RachelYeah, exactly. The medical community recently had to fundamentally change the way we even talk about this disease because our previous understanding was just it was missing the root cause.
MarkRight. So if listeners are familiar with fatty liver disease, they've probably heard the old acronym, you know, N-A-F-L-D.
RachelMm-hmm. Non-alcoholic fatty liver disease.
MarkTrevor Burrus, Jr.: AFLD. But the source material notes, we don't call it that anymore. Now it's M-A-S-L-D.
RachelRight.
MarkM-A-S-L-D. Metabolic dysfunction associated steatotic liver disease.
RachelAaron Ross Powell It is quite a mouthful.
MarkAaron Ross Powell It is. So why the sudden shift in terminology? Like why change it now?
RachelAaron Ross Powell Well, the shift was honestly overdue. The old name, NFLD, it defined the disease entirely by what it wasn't.
MarkTrevor Burrus, Right. It wasn't caused by alcohol.
RachelTrevor Burrus Exactly. But it completely ignored the actual driver of the pathology. So MASLD, it puts the spotlight exactly where it belongs on systemic metabolic dysfunction. I see. Aaron Ross Powell We are talking about the downstream effects of insulin resistance, visceral abdominal obesity, and type 2 diabetes. It's basically a whole body energy crisis that just happens to be taking its heaviest toll on the liver.
MarkAaron Powell I mean you say a heavy toll. The article cites the 2026 American Diabetes Association Standards of Care. Oh, yeah. Which estimate that over 70% of people with type 2 diabetes in the U.S. have MASLD.
Rachel70%. It's staggering. Aaron Powell.
MarkI mean, if you are treating someone's diabetes but ignoring their liver, you are effectively ignoring the engine of the disease.
RachelAaron Powell Exactly.
MarkBut I want to slow down and understand how this actually happens. Like, how does insulin resistance translate to a liver that's packed with fat?
How The Liver Makes New Fat
MarkAaron Powell Right.
RachelSo it comes down to a process called de novolepogenesis. Okay. So normally insulin acts as a key, right? It unlocks your cells so they can absorb glucose from your blood and use it for energy. Makes sense. But when you become insulin resistant, your cells stop responding to the key. So they are starving for energy while just, you know, swimming in a sea of blood sugar. Right. And in response, your pancreas basically panics and pumps out even more insulin to force the doors open.
MarkAaron Powell So you end up with high blood sugar and high insulin at the same time.
RachelAaron Ross Powell Exactly. And the liver has to deal with that fallout. The liver is forced to take all that excess energy, particularly from refined carbohydrates and a really heavy influx of fructose, and it converts it directly into fat.
MarkWow.
RachelIt manufactures new fat from scratch. That is the de novo lipogenesis.
MarkOkay, think of the liver like a busy shipping warehouse.
RachelOh, I like that.
MarkNormally its job is to process nutrients, pack them into molecular trucks called triglycerides.
RachelYeah, triglycerides.
MarkAnd export them perfectly. The trucks come in, the trucks roll out. But when the body is flooded with this excess energy, the warehouse basically runs out of trucks.
RachelAaron Ross Powell Exactly. It can't ship the fat out fast enough.
MarkRight. So it just starts stacking these boxes of fat right there in the aisles, piling them higher and higher until the sheer weight of it all makes the building itself start to crack.
RachelAaron Powell What's fascinating here is that initially that storage is actually a protective mechanism.
MarkAaron Powell Wait, really? Storing fat in the liver is protective.
RachelAaron Powell Yeah. Well, free-floating fatty acids in the bloodstream are highly toxic to organs like the heart and pancreas.
NicoletteOh, I see.
RachelSo the liver is kind of taking a bullet for the rest of the body by locking those toxic fatty acids away safely in those triglyceride boxes you mentioned. Wow. It's a localized makeshift solution to a systemic energy surplus.
MarkAaron Powell But it can't last forever. I mean, eventually the warehouse is completely
From Fat Storage To Fibrosis
Markfull.
RachelExactly. The system breaks down. And the liver transitions from simple fat storage into a stage called M-ESH, metabolic dysfunction associated with stetohepatitis. So the liver's mitochondria, the cellular power plants, they try to burn off the excess fat, but they get totally overwhelmed and they overheat. They start throwing off sparks, which we call reactive oxygen species. And that causes severe oxidative stress, which triggers active inflammation and cellular injury.
MarkSo the warehouse effectively catches on fire.
RachelYes.
MarkAnd that continuous cycle of injury and inflammation, it wakes up these specialized cells mentioned in our sources, the hepatic stellate cells.
RachelRight, right. So hepatic stellate cells, they usually just store vitamin A quietly.
MarkOkay.
RachelBut when they are bathed in inflammatory signals from dying liver cells, they transform, they activate and start aggressively laying down collagen.
MarkLike scar tissue.
RachelFibrosis. That is the clinical term for it. And fibrosis is the true danger here.
MarkRight.
RachelIt is the strongest predictor of whether a patient will progress to cirrhosis or complete liver failure or hepatocellular carcinoma, which is liver cancer.
MarkGosh.
RachelSo the fat is the fuel, the inflammation is the fire, but the fibrosis is the irreversible structural damage to the building.
MarkHearing that your liver is quietly filling up with concrete is terrifying.
Why AST And ALT Miss Scars
RachelIt is.
MarkWhich brings us to the most dangerous part of this entire deep dive, which is the illusion of the standard blood test. If the warehouse is on fire and the walls are cracking with scar tissue, why doesn't a standard physical catch it?
RachelWell, the liver is the ultimate stoic workaholic.
MarkYeah.
RachelIt possesses a massive functional reserve, meaning it can continue regulating glucose, clearing toxins, processing medications, doing its hundreds of daily tasks, even while heavily burdened by fat and scar tissue.
NicoletteWow.
RachelSo by the time a patient actually feels symptoms, which are usually just vague lingering fatigue or a mild, you know, dull ache under their right rib cage, the structural damage is often incredibly advanced.
MarkWait, hold on. I'm looking at my own blood work PDF in my head right now.
RachelOkay.
MarkIf my primary care doctor, who went to medical school for over a decade, tells me my AST and ALT liver enzymes are strictly inside the green reference range. Right. Why on earth should I trust a random math equation over their clinical judgment? Like, isn't the reference range established for a reason?
RachelIt is, but we have to critically examine how those reference ranges are built in the first place. Okay. Those normal brackets on your lab report are derived by taking a bell curve of the general population. Right. But in modern society, that general population inherently includes millions of people with unrecognized insulin resistance, obesity, and silent, undiagnosed MASLD.
MarkOh.
RachelThe curve is being graded on a fundamentally sick population.
MarkAaron Ross Powell So a normal score just means you're average, and the average person is metabolically unwell.
RachelExactly. And furthermore, we have to look at what AST and ALT actually measure. Okay. They are intracellular enzymes. When a liver cell is actively irritated or dying, its membrane ruptures and spills those enzymes into the bloodstream.
NicoletteRight.
RachelSo they measure current, active fire. They do not measure the amount of burnt ground. Oh wow. Yeah. They tell you nothing about the total volume of collagen scar tissue that has already been laid down.
MarkAaron Ross Powell, which means someone could have severe scarring. But if the active inflammation has momentarily calmed down, their enzymes look completely fine.
RachelExactly. And it gets even more deceptive in late stage disease.
MarkHow so?
RachelWell, once severe fibrosis or cirrhosis sets in, a massive portion of the liver tissue is effectively dead.
NicoletteOkay.
RachelThere are simply fewer healthy liver cells left to break open.
NicoletteRight.
RachelSo the AST and ALT levels can actually drop back down into the normal range, not because the patient is healing, but because they are quite literally running out of liver. Oh my gosh.
MarkWhich forces the medical community into a corner. I mean, if the standard interpretation of routine liver enzymes is actively failing patients, how do we find the hidden damage? Because nobody wants to undergo an invasive liver biopsy just for a screening.
RachelRight. Nobody wants that. So researchers realized they didn't need a new expensive invasive procedure. They needed a new lens to look at the data we were already collecting.
FIB-4 The Four-Number Screen
MarkAaron Powell Which brings us to the breakthrough. The FAB4 index.
RachelYes.
MarkFIB-4.
RachelIt is a risk stratification mathematical equation. And interestingly enough, it wasn't even designed for metabolic liver disease initially. Really? Yeah, it was originally developed in the early 2000s to assess fibrosis in patients co-infected with hepatitis C and HIV.
MarkOh wow.
RachelBut hepatologists realized the underlying mathematics map beautifully onto the scarring patterns of ASLD, too.
MarkAaron Powell So the formula uses just four inputs, four variables that are already sitting on a routine, comprehensive metabolic panel and a complete blood count. Age, AST, ALT, and platelet count. Let's break down why this specific combination of numbers is so revealing.
NicoletteOkay.
MarkSo age makes sense because your liver's regenerative capacity naturally declines and cumulative metabolic stress increases the older you get.
RachelExactly. Then you have the AST and ALT. But it isn't just about their absolute numbers. The formula relies heavily on the ratio between the two.
MarkThe ratio, okay.
RachelYeah. In a healthy person or someone with early mild fatty liver, ALT is typically higher than AST. Okay. But as fibrosis advances, mitochondrial damage becomes more severe, which releases a specific mitochondrial form of AST.
MarkAh, I see.
RachelAdditionally, the scarred liver loses its ability to clear AST from the blood. So the ratio flips. AST climbs higher than ALT.
MarkOh.
RachelAnd the math captures that inversion.
MarkBut the real genius of the formula, the part that genuinely blew my mind when reviewing the source material is the inclusion of the platelet count.
RachelOh, it's brilliant.
MarkBecause platelets are for blood clotting. If I get a paper cut, platelets stop the bleeding. Yeah. What could they possibly have to do with scars in my liver?
RachelIt is a brilliant piece of anatomical mechanics. So as fibrosis lays down that collagen, the liver tissue becomes stiff.
NicoletteOkay.
RachelImagine pouring concrete into a kitchen sponge.
NicoletteRight.
RachelBlood from your digestive tract is supposed to flow smoothly through that sponge via the portal vein. But if the sponge is filled with concrete, the blood hits severe physical resistance, it backs up.
MarkA massive vascular traffic jam.
RachelExactly. That traffic jam increases the pressure in the entire portal circulation system. Wow. Because the circulatory system is a closed loop, that backed up pressure has to go somewhere. And it forces the spleen to enlarge. A condition called splenomegaly. And an enlarged spleen begins to behave abnormally.
MarkWhat does it do?
RachelIt starts capturing and hoarding your platelets, pulling them out of the general bloodstream.
MarkAaron Powell So the platelet count on your routine blood test drops. Not because you have a rare blood clotting disorder, but because your stiff, scarred liver is causing a vascular traffic jam that forces your spleen to hoard the platelets.
RachelYes. So while your platelet count might technically still register as you know normal on a lab report, that subtle downward trend combined with your age and that flipping AST to ALT ratio. Right. It creates a highly specific mathematical fingerprint of silent scarring.
MarkAaron Powell Here's where it gets really interesting because the math gives you a specific numerical score. It isn't a diagnostic tool that definitively proves you have cirrhosis. Right. It operates more like a sorting hat to figure out who actually needs a closer look, saving the healthcare system from doing biopsies on everyone.
RachelAaron Powell Exactly. And the scoring thresholds are very straightforward.
Cutoffs Plus Key Age Caveats
RachelIf your F4 score is below 1.3, you are generally considered low risk for advanced fibrosis.
MarkOkay, so that's good. Yeah.
RachelYeah. It suggests severe scarring is unlikely at this moment. And you can focus on monitoring and improving your baseline metabolic health with your primary care provider.
MarkAaron Powell And if the math pushes you higher.
RachelIf your score lands between 1.3 and 2.67, you fall into the in indeterminate zone.
MarkThe gray area.
RachelThe math cannot rule out advanced fibrosis. And if your score breaches 2.67, that indicates a high probability of advanced fibrosis. That warrants an immediate referral to a gastroenterologist or hepatologist.
MarkAaron Powell But the article from Quick Lab Mobile includes some crucial caveats like the FIB4 is a tool, not an oracle, and the math has limits.
RachelDefinitely. It is highly context dependent. First, the index has not been well validated for adults under the age of 35.
MarkWhy is that?
RachelBecause age is a multiplier in the equation. So being young can artificially suppress the final score, potentially masking a real problem. Conversely, for adults age 65 and older, their age naturally inflates the score.
MarkAaron Powell Oh, so they might get a false positive.
RachelExactly. So to prevent over-referring healthy seniors to specialists, the low risk threshold for that demographic shifts from 1.3 up to 2.0.
MarkAaron Ross Powell That makes sense. You also have to consider acute variables that can temporarily ruin the math, right?
RachelYes.
MarkLike ASD and ALT can spike from immediate short-term stressors.
RachelAbsolutely.
MarkIf you run a marathon or do a grueling weightlifting session the day before your blood draw, or if you're fighting off a viral illness. Yeah. Or even if you just had a few too many drinks over the weekend, those enzymes will jump.
RachelThey will. The FAB four requires clinical context. You cannot calculate your score the morning after a strenuous event and panic over the result.
MarkRight.
RachelIt is meant to assess chronic baseline levels. Aaron Powell Okay.
MarkLet's put this into practice. Okay. A listener logs into their portal, finds a free FAB4 calculator online, inputs their numbers, and scores a 1.8.
RachelOkay.
MarkThey are in the indeterminate zone. The sorting hat says we need a closer look. What is the actual next step?
FibroScan And The ELF Test
RachelThe next step moves away from mathematical risk and into physical measurement. The gold standard non-invasive follow-up is transient elastography, most commonly known by its brand name, fiberskin.
MarkIt's an incredible piece of technology.
RachelIt really is. It is an ultrasound device, completely painless, that sits on the skin over the liver and sends a small, controlled mechanical shear wave, like a vibration through the tissue. It measures the exact velocity of that wave to determine the stiffness of the organ.
MarkBecause again, scars are stiff, the concrete in the sponge, sound waves travel faster through dense, stiff materials.
RachelAaron Powell Exactly. And the device measures that stiffness in kilopascals. So according to the 2026 guidelines, if your result is under 8.0 kilopascals, advanced fibrosis is highly unlikely.
MarkOkay, good to know.
RachelYeah, you can usually remain under the care of your primary doctor, but if the stiffness is 8.0 or higher, the structural damage is present and you need specialized care.
MarkAaron Powell And what if a patient is in a rural area or simply doesn't have access to a fibroscan machine?
RachelWell, in that case, hepatologists utilize an alternative blood test called the ELF test, the enhanced liver fibrosis test.
MarkOkay, how is that different from AST and ALT?
RachelInstead of looking at generic liver enzymes, the ELF test measures three highly specific circulating proteins that are directly involved in the biological formation and breakdown of the collagen extracellular matrix.
NicoletteOh wow.
RachelYeah. And a score below 9.8 generally indicates a lower risk of severe scarring.
MarkOkay, so the math sounds the alarm, and the fibers scan or ELF test confirms the concrete is there.
RachelRight.
MarkThis is where we need to talk about intervention. Because hearing
Reversal With Weight Muscle And Diet
Markthat your liver has structural scarring sounds incredibly fatalistic. Tell me this isn't a one-way street. Can this organ actually rebuild itself?
RachelIt can. The liver is arguably the most remarkably regenerative organ in the human body.
MarkThat's amazing.
RachelYes, it can heal. The initial fat accumulation, the raging inflammation of MH, and even early to moderate stages of fibrosis can be reversed if you remove the metabolic stress that is driving the pathology.
MarkAaron Powell And the source material gets very specific about this. It's not just generic advice to, you know, eat better. It requires targeted metabolic relief.
RachelAaron Powell Right. Body composition plays a massive role here. Losing just five percent of your total body weight can significantly drain the fat trapped inside the liver cells.
MarkWow, just five percent.
RachelJust five percent. And if a patient achieves seven percent to ten percent weight loss, clinical trials show actual histological improvements.
MarkMeaning what? Exactly.
RachelMeaning the MASH inflammation subsides, and the body actually begins to dissolve and clear the fibrotic scar tissue.
MarkAaron Powell That is incredible. But it's not just about losing weight, it's about what you do with your body's energy. The article highlights that skeletal muscle is the body's largest glucose disposal sink. Yes. So if you engage in resistance training, building and maintaining muscle mass, you are quite literally building a larger reservoir for excess blood sugar.
RachelYeah.
MarkYou are giving the energy a place to go that isn't the liver.
RachelExactly. And you must stop forcing the liver to perform de novo lipogenesis. By drastically reducing the intake of sugar-sweetened beverages, refined carbohydrates, and highly concentrated fructose, you basically shut down the toxic assembly line. Trevor Burrus, Jr.
MarkYou give the mitochondria a chance to catch their breath.
RachelExactly, and clear the backlog.
New Drugs For MASH And Fibrosis
MarkAaron Powell But you know, lifestyle intervention has always been the standard advice. What makes 2026 so different is the pharmaceutical landscape. We now have actual medical interventions.
RachelIt is a monumental shift. Yeah. The FDA has now approved medications specifically for this. We are seeing GLP1 receptor agonists, like semaglutide, approved for adults with MSH and moderate to advanced fibrosis.
MarkNow, most people listening know semaglutide as a blockbuster weight loss drug. Why is it being used for liver scarring?
RachelWell, while the weight loss certainly drains the fat, GLP1 receptors are also located on immune cells.
NicoletteOh.
RachelSo semaglutide seems to directly reduce systemic inflammation, cooling off the hepatic stellate cells, and giving the liver the environment it needs to halt the fibrosis progression.
MarkWow. But even more targeted is a newer drug called resmatyrum, sold under the brand name resdifra.
RachelYes, resdifra.
MarkHow does resmatyrum work at a cellular level?
RachelIt is a triumph of targeted pharmacology. It is a thyroid hormone receptor beta agonist.
MarkAaron Ross Powell Okay, break that down for us.
RachelSo your thyroid hormones regulate your overall metabolism, right?
MarkRight.
RachelIn the liver, the specific beta receptor controls how efficiently the liver breaks down fatty acids. So resmetharom selectively binds to that specific receptor in the liver, effectively turning the furnace up on high to burn off the toxic lipids.
MarkAaron Powell Without affecting the rest of the body.
RachelExactly. Without overstimulating the heart or giving the patient systemic hyperthyroidism.
MarkIt just cranks the engine in the liver to clear the backlog.
RachelYeah.
MarkBut the article makes it very clear these drugs are strictly gatekeeped. You cannot just calculate a high FE4 score on your phone and demand a prescription from your doctor.
RachelOh, absolutely not. The FAB4 is the screening tool, not the definitive diagnosis. Patients still must undergo the elastography and a thorough specialist evaluation to clinically prove the presence of veg SH and significant fibrosis before these heavy-duty medications are deployed.
MarkBecause you have to be treating the right problem.
RachelExactly. If we connect this to the bigger picture, treating the liver is ultimately about treating the entire cardiometabolic
ApoB And Cardiovascular Spillover
Rachelsystem.
NicoletteRight.
RachelIf your liver is dysfunctional, your cardiovascular system is in immediate danger. That is where advanced lipid panels become critical.
MarkOkay.
RachelSpecifically looking at APOB.
MarkOkay. Let's break down APOB. We hear a lot about LDL cholesterol, the so-called bad cholesterol. How is APOB different and how does it relate to a scarred liver?
RachelSo think of cholesterol as cargo and APOB as the physical cargo ships carrying it through your bloodstream.
MarkOh, I like that analogy.
RachelYeah. So APOB measures the exact number of atherogenic or plaque-causing particles in your blood. Okay. When the liver is burdened by MAHH and insulin resistance, it starts manufacturing and shipping out an excessive number of these highly dangerous, small, dense APO particles.
MarkOh wow.
RachelSo MASLD and cardiovascular disease are practically two sides of the same metabolic coin.
MarkSo what does this all mean? If we zoom out and look at everything we've unpacked today from the Quick Lab mobile deep dive, it means that relying on a routine physical where a doctor glances at your AST and ALT and says you are normal is absolutely not a free pass.
RachelIt's not.
MarkEspecially if you are one of the millions of people dealing with type 2 diabetes, prediabetes,
The Big Preventive Medicine Shift
Markor abdominal obesity.
RachelExactly. The immense functional reserve of your liver will hide the structural damage until you are practically on the precipice of liver failure.
MarkAaron Powell But the FIB 4 index empowers you to look behind the curtain.
RachelIt does.
MarkYou don't need to wait for a doctor to order an invasive biopsy. You can take the data you already have, your age, your AST, your ALT, and your platelet count, and run the math yourself.
NicoletteYeah.
MarkIt is a mathematical sorting hat that can warn you about a silent fire while there is still time to rebuild the warehouse.
RachelAaron Powell It really represents a fundamental paradigm shift in preventative medicine.
MarkYeah.
RachelAnd I'll leave you with this final thought to mull over. Okay. The liver is the body's central metabolic engine. Yet for decades we've only been testing it for active damage by looking at those bursting enzymes rather than testing for underlying stress and physical structural change. Right. The FIB4 index proves that a simple mathematical formula can uncover hidden dangers just by recombining old routine data in a new way. Makes you wonder, what other life-saving health secrets are currently hiding in our routine, normal lab results, just waiting for someone to invent the right mathematical formula to unlock them?
MarkThat is a wild thought.
RachelIt is.
MarkThe data is all there. We just have to learn how to read it. Well, until next time, keep digging, keep asking questions, and we'll see you on the next deep dive.
Subscribe Share And Learn More
NicoletteThanks for tuning into the health poll. If you found this episode helpful, don't forget to subscribe and share it with someone who might benefit. For more health insights and diagnostics, visit us online at www.quicklabmobile.com. Stay informed, stay healthy, and we'll catch you in the next episode.
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
